The Dana-Farber Cancer Institute initiated retractions or corrections to 37 papers authored by four senior researchers following allegations of data falsification, a DFCI research integrity officer said on Sunday.
In the emailed statement to The Crimson, DFCI Research Integrity Officer Barrett J. Rollins wrote that six manuscripts have retractions underway and 31 are being corrected.
The corrections come amid claims of data manipulation against DFCI President and CEO Laurie H. Glimcher ’72, Executive Vice President and COO William C. Hahn ’87, Senior Vice President for Experimental Medicine Irene M. Ghobrial, and Harvard Medical School professor Kenneth C. Anderson. The allegations of misconduct were first compiled and publicized in a Jan. 2 blog post by data sleuth Sholto David.
[These are not salad days at the university with the motto of “Veritas,” eh? The board hired a barely-published plagiarist as president, and then initially scoffed at the allegations as minor and unconcerning. It now looks as though shoddy and fraudulent work has become the norm at Harvard. I wonder how much wrongdoing would emerge from scrutiny of other areas of research at the university? — Ed]
Join the conversation as a VIP Member